// App-Quantinova.ai

4780 : RXDX-107 exhibits multiple mechanisms of intracellular delivery and results in extensive drug-induced interstrand crosslinks in solid tumor preclinical models

Researchers

Presenter

  • Leenus Martin

Principal Investigators

  • Roopal Patel

  • Michael Johnson

  • Jerry Cao

  • Peter Chua

  • Colin Walsh

  • Jennifer Oliver

  • Pratik Multani

  • Robert Wild

  • Ralph Lin

  • Gary G. Li

Medical Centers

  • Ignyta, Inc, San Diego, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Human albumin

Drug/Treatment

  • Human serum albumin

  • Bendamustine

  • RXDX-107

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved